Key result
DOAC reversal agents evaluated for intracerebral hemorrhage lack clinical results in the provided abstract.
No clinical results available from this DOAC reversal meta-analysis in ICH; leaves open questions on efficacy and safety.
To evaluate the efficacy and safety of direct oral anticoagulant (DOAC) reversal agents in patients with intracerebral hemorrhage (ICH).
No takes yet. Share an insight, caveat, or question.
Abdelkader et al. (2026) studied this question. Direct oral anticoagulant reversal agents were evaluated for efficacy and safety in intracerebral hemorrhage, but the provided abstract contains no clinical results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: